KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 108 filers reported holding KURA ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 11.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,269,600 | -66.2% | 120,000 | +4.3% | 0.30% | -38.9% |
| Q4 2020 | $3,756,000 | -19.2% | 115,000 | -51.3% | 0.50% | -58.8% |
| Q2 2019 | $4,646,000 | +45.9% | 235,956 | +34.8% | 1.20% | +98.5% |
| Q2 2018 | $3,185,000 | +349.2% | 175,000 | 0.0% | 0.61% | -53.2% |
| Q1 2016 | $709,000 | +29.4% | 175,000 | +168.3% | 1.30% | +18.7% |
| Q4 2015 | $548,000 | – | 65,222 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |